Penny Asbell

Dr. Penny Asbell


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
EKEric J. Kuklinski
Eric J. Kuklinski
YYYinxi Yu
Yinxi Yu
GYGui-Shuang Ying
Gui-Shuang Ying
Penny AsbellPenny Asbell
Penny Asbell
FGfor the DREAM Study Research Group
for the DREAM Study Research Group
Purpose: Dry eye disease (DED) is a multifactorial, heterogeneous disease of the ocular surface with one etiology being ocular surface inflammation. Studies using animal models demonstrate the role of ocular surface immune cells in the inflammatory pathway leading to DED, but few have evaluated humans. This study described the white blood cell population from the ocular surface of patients with DED and assessed its association with DED signs and symptoms in participants of the Dry Eye Assessment and Management (DREAM) study. Methods: Participants were assessed for symptoms using the Ocular Surface Disease Index, signs via corneal staining, conjunctival staining, tear break-up time, and Schirmer test, and Sjögren's syndrome (SS) based on the 2012 American College of Rheumatology classification criteria. Impression cytology of conjunctival cells from each eye was evaluated using flow cytometry: T cells, helper T cells (Th), regulatory T cells (Tregs), cytotoxic T cells, and dendritic cells. Results: We assessed 1049 eyes from 527 participants. White blood cell subtype percentages varied widely across participants. Significant positive associations were found for Th and conjunctival staining (mean score of 2.8 for 0% Th and 3.1 for >4.0% Th; P = 0.007), and corneal staining (mean score of 3.5 for 0% Th and 4.3 for >4.0% Th; P = 0.01). SS was associated with higher percent of Tregs (median 0.1 vs. 0.0; P = 0.01). Conclusions: Th were associated with more severe conjunctival and corneal staining, possibly indicating their role in inflammation leading to damage of the ocular surface. There is no consistent conclusion about Tregs in SS, but these results support that Tregs are elevated in SS.

22 August 2023 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Open access
Penny AsbellPenny Asbell
Penny Asbell
CSChristine M. Sanfilippo
Christine M. Sanfilippo
HDHeleen H. DeCory
Heleen H. DeCory
Antibiotic resistance in bacterial ocular infections is of significant clinical concern and may affect treatment outcomes. We report on in vitro antibiotic susceptibility rates and trends among conjunctival-sourced isolates collected in the Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) surveillance study. A total of 2214 conjunctival isolates (918 Staphylococcus aureus, 589 coagulase-negative staphylococci [CoNS], 194 Streptococcus pneumoniae, 171 Pseudomonas aeruginosa, and 342 Haemophilus influenzae) obtained between 2009-2021 were analyzed. Staphylococci were commonly resistant to azithromycin (≥54.8%) and oxacillin (≥29.3%). Resistance among S. pneumoniae isolates was notable for azithromycin (34.0%) and penicillin (28.9%), while P. aeruginosa and H. influenzae isolates were highly susceptible to most tested antibiotics. Methicillin-resistant staphylococci demonstrated greater concurrent resistance to other antibiotics than methicillin-susceptible isolates and exhibited high rates of multidrug resistance (≥74.0%). Among staphylococci, antibiotic resistance increased with patient age, and there were small decreases in resistance to several drugs over the 13-year period. These findings indicate that resistance to antibiotics routinely used in ophthalmic practice remains high among conjunctival isolates.

11 January 2023 in Current Eye Research
Verified
Journal Article
Closed access
NRNeeta S. Roy
Neeta S. Roy
YWYi Wei
Yi Wei
GYGui-Shuang Ying
Gui-Shuang Ying
MMMaureen G. Maguire
Maureen G. Maguire
Penny AsbellPenny Asbell
Penny Asbell
FGfor the Dry Eye Assessment and Management (DREAM) Study Group
for the Dry Eye Assessment and Management (DREAM) Study Group
To describe tear concentrations of IL-1β, Il-6, IL-8, IL-10, IL-17A, IFNγ and TNFα in tears, collected by microcapillaries, and their correlation with symptoms and signs in subjects with dry eye di...

12 September 2024 in Current Eye Research
Verified
Journal Article
Closed access
CZCindy S Zhao
Cindy S Zhao
YCYineng Chen
Yineng Chen
YYYinxi Yu
Yinxi Yu
GYGui-Shuang Ying
Gui-Shuang Ying
Penny AsbellPenny Asbell
Penny Asbell
FGfor the Dry Eye Assessment and Management (DREAM) Study Group
for the Dry Eye Assessment and Management (DREAM) Study Group
To extend cross-sectional data on cytokine ratios (CRs) in dry eye disease (DED) signs by investigating longitudinal change in pro- to anti-inflammatory CRs and associations with change in DED signs and symptoms. Secondary analysis of fifty-four subjects [mean age 57.3 (SD 13.2) years, 85.2% female; 68.5% white] with ≥ 4 uL pooled tear volumes at months 0, 6, and 12. Pro-inflammatory (IL-1b, IL-6, IL-8, IL-17A, IFN-g, and TNF-a) to anti-inflammatory (IL-6, IL-10) cytokine ratios (CR) were calculated. DED signs (corneal and conjunctival staining scores, tear break-up time, Schirmer test, Meibomian gland plugging, tear osmolarity, composite sign severity score) and symptoms [Ocular Surface Disease Index (OSDI)] were measured. Changes over time in DED signs, symptoms, and CRs were evaluated using longitudinal models. Correlations between changes in CR and changes in DED signs and symptoms were evaluated using Spearman correlation coefficients (rho). DED signs which improved over time (p < 0.001) included corneal and conjunctival staining score, tear break-up time, tear osmolarity, and composite sign severity score. Using IL-10 as anti-inflammatory, changes in corneal and conjunctival staining and composite severity score significantly correlated with changes in pro- to anti-inflammatory CRs from month 0 to 6 (|rho|: 0.29-0.45, p: 0.003-0.04) but not between month 0 to 12 (|rho|: 0.01 to 0.24, all p > 0.08). DED symptoms decreased across one year (p < = 0.001) for all OSDI measures; these changes did not correlate with changes in CRs (|rho|: 0.00 to 0.29, all p > 0.04). Improvement in some DED signs across one year correlated weakly with decreases in pro- to anti-inflammatory CRs, in alignment with the understanding of DED as inflammatory. CRs may provide greater insight than absolute tear cytokine concentrations as possible DED biomarkers. Additional studies that provide standardized clinical information and tear collection and analysis are needed to validate CRs in DED.

12 February 2024 in Current Eye Research
Verified
Journal Article
Closed access
MHMarium H. Hashemi
Marium H. Hashemi
JAJulian L. Ambrus
Julian L. Ambrus
ASAbhay A. Shukla
Abhay A. Shukla
DZDi Zhu
Di Zhu
GYGui-Shuang Ying
Gui-Shuang Ying
DGDry Eye Assessment and Management (DREAM) Study Research Group
Dry Eye Assessment and Management (DREAM) Study Research Group
Purpose To evaluate the possible role of systemic inflammation in dry eye disease (DED) via systemic inflammatory marker associations with DED signs and symptoms, and an analysis of a subgroup with Sjogren's Syndrome (SS). Methods Participant serums were analyzed using line immunoassays (LIAs) for the presence of antibodies against 34 systemic inflammatory markers. Using the 2012 American College of Rheumatology definition, the 481 participants were categorized into group 1 (SS; n = 52), group 2 (autoimmune disease not including SS; n = 66), or group 3 (control, i.e. no autoimmune disease; n = 363). Results 3 markers were positive in >= 10% of participants: Ro52 (19.3%), Scl-70 (15.0%), CN-1A (14.2%). 2 markers were positively associated with symptoms: PM-Scl100 (p = 0.02), Sm (p = 0.009). 5 markers were positively associated with signs: U2SnRNP A', Ro52, La, DNA, Ro60. SS participants showed significantly higher positivity for 4 markers compared to participants with no autoimmune disease: PL-7 (p = 0.02), Ro52 (p < 0.0001), La (p < 0.0001), Ro60 (p < 0.0001). SS participants showed significantly higher positivity for 3 markers compared to participants with another autoimmune disease: Ro52 (p < 0.0001), La (p = 0.002), Ro60 (p < 0.0001). Conclusions This study did not show evidence of significant systemic inflammation in participants with moderate-to-severe DED, based on the markers tested. PM-Scl100 and Sm may be associated with more severe DED symptoms. U2SnRNP A', Ro52, La, DNA, and Ro60 may be associated with more severe ocular surface disease. Ro52 and PL-7 may be diagnostic markers for SS. Future research evaluating these relationships and their clinical significance is needed.

12 April 2025 in Contact Lens and Anterior Eye
Verified
Journal Article
Open access
DJDivya Jagadeesh
Divya Jagadeesh
MLMeng C. Lin
Meng C. Lin
Fiona StapletonFiona Stapleton
Fiona Stapleton
JHJocelyn He
Jocelyn He
GYGui-Shuang Ying
Gui-Shuang Ying
Penny AsbellPenny Asbell
Penny Asbell
Meibomian gland dysfunction (MGD) is a common disease, yet there is no standard clinical definition. This study explored the frequency and characteristics of MGD in dry eye disease (DED) using different clinical definitions. A secondary analysis of data collected from the DREAM© study participants (n = 535) with moderate-to-severe DED was undertaken. Three common MG clinical features; plugging, secretion quality, and MG atrophy grade, either separately or in combination were used to create MGD definitions. The frequency of MGD, defined by the per eye findings, was reported. Demographic characteristics were compared between those with and without MGD. The frequency of MGD in DED varied from 12 % (gland plugging, plus poor secretion quality plus gland atrophy) to 55 % (gland plugging alone) of eyes. Older age was associated with MGD when atrophy-based definitions were used (p < 0.001) but was not associated with MGD definitions using plugging or secretion quality (p > 0.05). After adjustment for age and between-eye correlations, MGD frequency was higher in women for definitions based on lower lid gland atrophy (adjusted p < 0.05). Hispanic or Latino ethnicity was more commonly associated with MGD than other ethnicities (adjusted p < 0.001), for definitions based on plugging and secretion quality. The frequency of MGD in DED varied with MGD definition. The highest frequency occurred where MGD was defined as lower eyelid gland plugging. Gland atrophy increased with age. The variation in disease frequency has implications for clinical diagnosis and determining efficacy assessment in intervention studies.